Ceritinib 150 mg
$380.00 – $1,020.00Price range: $380.00 through $1,020.00
Ceritinib 150 mg – Targeted ALK Inhibitor for Advanced Lung Cancer
Ceritinib 150 mg is a prescription medication used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by selectively targeting and inhibiting the anaplastic lymphoma kinase (ALK), a protein responsible for the growth of certain lung cancers.
This therapy is intended for adult patients whose tumors are ALK-positive, as confirmed by FDA-approved testing methods, especially those who have developed resistance or intolerance to previous ALK inhibitor treatments like Crizotinib.
How It Works:
Ceritinib blocks the activity of the abnormal ALK protein, preventing it from sending signals that promote cancer cell survival and proliferation. By disrupting this pathway, Ceritinib slows tumor growth, reduces tumor size, and helps control disease progression. Its targeted action allows for greater specificity and fewer off-target effects compared to traditional chemotherapy.
Indications:
-
ALK-positive metastatic non-small cell lung cancer (NSCLC)
-
Patients previously treated with or intolerant to other ALK inhibitors
-
Cancer cases exhibiting ALK gene rearrangement confirmed by diagnostic testing
Key Benefits:
-
Contains 150 mg of Ceritinib per capsule
-
Effective against ALK-positive NSCLC, including resistant tumors
-
Targets cancer at the molecular level
-
Oral, once-daily administration
-
FDA-approved for use in specific advanced lung cancer cases
-
Helps slow progression and improve quality of life
-
Can be used as first-line or subsequent-line therapy based on clinical need
Dosage and Administration:
Ceritinib is usually taken once daily with food, as recommended by your oncologist. Dosage may vary depending on liver function, tolerability, and other medications. Common side effects include nausea, diarrhea, liver enzyme changes, and fatigue. Regular monitoring of liver function and blood tests is recommended during treatment.
Take a step forward in precision cancer care with Ceritinib 150 mg, available now at QuickRxHub. Enjoy secure online ordering, discreet packaging, and reliable worldwide shipping. Trust in targeted therapy to help manage advanced ALK-positive NSCLC more effectively.
